Paper7442467
Nortriptyline and antipyrine clearance in relation to debrisoquine hydroxylation in man.
Bertilsson L and 5 others. Life Sci, 1980. Cited by 132 papers, by iCite.
Cite this record
ConductScience Library. Nortriptyline and antipyrine clearance in relation to debrisoquine hydroxylation in man. Papers, record 7442467. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7442467
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antipyrine | Major topic |
| Debrisoquin | Major topic |
| Isoquinolines | Major topic |
| Nortriptyline | Major topic |
| Adult | |
| Female | |
| Humans | |
| Hydroxylation | |
| Kinetics | |
| Male | |
| Middle Aged | |
| Oxidation-Reduction | |
| Phenotype | |
| Saliva |
Source PubMed
Cited by38
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 132 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39832006 | Validating the accuracy of mathematical model-based pharmacogenomics dose prediction with real-world data. | Eur J Clin Pharmacol | 2025 | https://conductscience.org/library/papers/39832006 | PubMed |
| 27942231 | CYP2D6 polymorphisms and their influence on risperidone treatment. | Pharmgenomics Pers Med | 2016 | https://conductscience.org/library/papers/27942231 | PubMed |
| 23226054 | Antidepressant-induced akathisia-related homicides associated with diminishing mutations in metabolizing genes of the CYP450 family. | Pharmgenomics Pers Med | 2011 | https://conductscience.org/library/papers/23226054 | PubMed |
| 22688624 | Impact of CYP2D6 polymorphism on tamoxifen therapy: where are we? | Wien Med Wochenschr | 2012 | https://conductscience.org/library/papers/22688624 | PubMed |
| 22389859 | Pharmacogenetics and gender association with psychotic episodes on nortriptyline lower doses: patient cases. | ISRN Pharm | 2011 | https://conductscience.org/library/papers/22389859 | PubMed |
| 21453273 | Clinically relevant genetic variations in drug metabolizing enzymes. | Curr Drug Metab | 2011 | https://conductscience.org/library/papers/21453273 | PubMed |
| 15037866 | Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response. | Mol Psychiatry | 2004 | https://conductscience.org/library/papers/15037866 | PubMed |
| 14618296 | Cytochrome P450 2D6: overview and update on pharmacology, genetics, biochemistry. | Naunyn Schmiedebergs Arch Pharmacol | 2004 | https://conductscience.org/library/papers/14618296 | PubMed |
| 11851634 | Molecular genetics of CYP2D6: clinical relevance with focus on psychotropic drugs. | Br J Clin Pharmacol | 2002 | https://conductscience.org/library/papers/11851634 | PubMed |
| 10533699 | Optimal sampling times for Bayesian estimation of the pharmacokinetic parameters of nortriptyline during therapeutic drug monitoring. | J Pharmacokinet Biopharm | 1999 | https://conductscience.org/library/papers/10533699 | PubMed |
| 9084960 | Use of in vitro and in vivo data to estimate the likelihood of metabolic pharmacokinetic interactions. | Clin Pharmacokinet | 1997 | https://conductscience.org/library/papers/9084960 | PubMed |
| 8867869 | Steady-state plasma levels of nortriptyline and its 10-hydroxy metabolite: relationship to the CYP2D6 genotype. | Psychopharmacology (Berl) | 1996 | https://conductscience.org/library/papers/8867869 | PubMed |
| 8839684 | Population pharmacokinetics and pharmacodynamics: potential use for gathering dose-concentration-response. | Eur J Drug Metab Pharmacokinet | 1996 | https://conductscience.org/library/papers/8839684 | PubMed |
| 8005189 | Nonlinear kinetics of nortriptyline in relation to nortriptyline clearance as observed during therapeutic drug monitoring. | Eur J Clin Pharmacol | 1994 | https://conductscience.org/library/papers/8005189 | PubMed |
| 7893588 | Population pharmacokinetics of nortriptyline during monotherapy and during concomitant treatment with drugs that inhibit CYP2D6--an evaluation with the nonparametric maximum likelihood method. | Br J Clin Pharmacol | 1994 | https://conductscience.org/library/papers/7893588 | PubMed |
| 7712660 | Active hydroxymetabolites of antidepressants. Emphasis on E-10-hydroxy-nortriptyline. | Clin Pharmacokinet | 1995 | https://conductscience.org/library/papers/7712660 | PubMed |
| 7106157 | Biotransformation of amitriptyline in depressive patients: urinary excretion of seven metabolites. | Eur J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/7106157 | PubMed |
| 7082544 | 6 beta-hydroxycortisol excretion in relation to polymorphic N-oxidation of sparteine. | Br J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/7082544 | PubMed |
| 7082530 | Assay and characterisation of debrisoquine 4-hydroxylase activity of microsomal fractions of human liver. | Br J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/7082530 | PubMed |
| 7042170 | Defective oxidation of drugs: pharmacokinetic and therapeutic implications. | Clin Pharmacokinet | 1982 | https://conductscience.org/library/papers/7042170 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7442467
GET https://conductscience.org/api/papers/v1/7442467/cited_by?page=2